Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03018717
Other study ID # ATLAN_TIC01
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 13, 2016
Est. completion date September 13, 2019

Study information

Verified date September 2018
Source Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Information and communications technologies (ICT) currently constitute a key element in the innovation and improvement of providing health-care to frail populations with advanced chronic diseases, but it´s efficacy, safety and cost-effectiveness has not yet been proven conclusively. The investigators are going to carry out a multi-center, randomized, parallel groups, phase III clinical trial in adult patient with heart and/or lung advanced diseases,aiming to analyze the efficacy and cost-efficacy of tele-monitorization of bio-parameters added to optimal standard of clinical care (shared clinical care plan) compared to the shared clinical care plan exclusively.


Description:

a total number of 510 patients will be divided in 3 centers: Hospital University Virgen del Rocío; Hospital University Virgen Macarena and Public Hospital Comarcal of Serranía de Ronda. Patient will be randomized in Tele-monitoring Constant (TELEPAC) To analyze the efficacy and cost-efficacy of incorporating tele-monitoring of bio-parameters into the shared comprehensive clinical care plan or in Standard Clinical Care (PAC) based on a comprehensive clinical assistance shared between Primary Care and Hospital Care.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 510
Est. completion date September 13, 2019
Est. primary completion date September 26, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Majority legal age (18 years of age or older)

- Present any of the following shortcomings:

Heart failure with baseline dyspnea =III of New York Heart Association (NYHA) Chronic respiratory insufficiency with basal dyspnea =III of Medical Research Council (MRC) Scale and / or oxygen saturation <90% and / or home oxygen therapy.

- Present Heart Failure or Respiratory Insufficiency with basal dyspnea grade <III (according to NYHA and MRC respectively) but have presented 2 or more income in the last year.

- Score of Patients with terminal or palliative medical diseases (score PALIAR) index between 0 and 7 points.

- To present one of the following assistance situations: hospital admission, follow-up in Home Hospitalization or Palliative Care Teams, specialized outpatient follow-up.

- Speak, understand, read and write Spanish, either the patient or the primary caregiver.

- Have basic knowledge of the use of mobile phones and applications of computer tablets (such knowledge will be confirmed by personal interview, with test of the device).

- Informed consent to participate in the study

Exclusion Criteria:

- Presence of malignant neoplastic disease ACTIVE except localized adenocarcinoma of prostate in hormonal treatment, and / or cutaneous basocellular-squamous cell carcinoma.

- In the case of Chronic Renal Disease if there is the possibility of entry into Substitutive Therapies (hemodialysis or transplantation)

- In the case of chronic liver disease, if there is a possibility of liver transplantation.

- Chronic neurological disease with established cognitive impairment (E. Pfeiffer with 7 or more errors and / or Mild cognitive evaluated (ECM with =18 points).

- Clinical situation of agony.

- Surprise question ("Would you be surprised if your patient died in the next 6 months?") With the result "I would not be surprised" + PALIAR Score Score =7.5 points.

- Participate in another tele-health initiative.

- Go simultaneously to a private health service and / or be institutionalized

Study Design


Intervention

Other:
Telemonitoring Constant
telemedicine of Constant
Standard clinical care
The patient will self-monitor heart rate, blood pressure, weight, diuresis, and capillary glycemia (in the case of diabetes)

Locations

Country Name City State
Spain Complejo Hospitalario de Jaén Jaén
Spain Serranía de Ronda Hospital Ronda Málaga
Spain Hospital Universitario de Valme Sevilla
Spain Universitary Hospital Virgen del Rocío Sevilla Seville
Spain Universitary Hospital Virgen Macarena Sevilla Seville

Sponsors (4)

Lead Sponsor Collaborator
Fundación Pública Andaluza Progreso y Salud Agency of Social Services and Dependency of Andalusia, Salud Responde, Telefónica S.A.

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reduce the number of hospital admissions and / or the number of hospital emergency visits and / or the number of primary care visits of the patients in the TELEPAC arm (patients with tele-monitoring) with respect to the PAC arm (patient without tele-Moni Monitoring number of hospitalizations and/or number of emergency visits in the period. Six month
Secondary Number of hospital admissions six month
Secondary Safety by monitoring of adverse events and adverse clinical events related to the two arms of the clinical trial analyze the safety of the two arms by monitoring the number of adverse events and adverse clinical events related to the two arms of the clinical trial. six month
Secondary quality of life related to health, of follow-up in both arms of the clinical trial, Using a standardized Using a standardized questionnaire of quality of live related to health in adults (EQ-5D) adapted to Spanish. At the time of inclusion, at 45 days and after 6 months of follow-up.
Secondary quality of care and satisfaction perceived by the subjects in the two arms of the clinical trial. Using the standardized questionnaire Service Performance (SERVPERF) adapted to health. at 45 days and after 6 months of follow-up
Secondary perceived quality and satisfaction with the technological instruments by the subjects in the two arms of the clinical trial. Using the Perceived quality for technical support (TSUQ) standardized questionnaire adapted at 45 days and after 6 months of follow-up,
Secondary primary cost-effectiveness of the arm TELEPAC with respect to the arm PAC, using the incremental cost method. using each of the patients that did not require hospital admission and / or emergency visits, as a unit of cost Of each patient. six month
Secondary To analyze the secondary incremental cost-effectiveness of the TELEPAC arm with respect to the PAC arm. using each of the secondary efficacy variables as unit of cost and each patient's overall cost unit. six month
Secondary Number of admissions-visits to Hospital Emergency six month
Secondary Number of visits to Primary Care Emergencies six month
Secondary mortality six month
Secondary Number of days of hospital stay six month
Secondary Overall cost for patients in euros six month
See also
  Status Clinical Trial Phase
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Completed NCT00783978 - Surfactant Disorders and Chronic Lung Disease N/A
Not yet recruiting NCT05025774 - Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
Completed NCT04663685 - MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults. N/A
Recruiting NCT06112730 - Nutritional Supplementation in Patients With Chronic Respiratory Disease N/A
Not yet recruiting NCT03180164 - Depression in Chronic Airways Diseases N/A
Completed NCT02544984 - The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease N/A
Recruiting NCT01721655 - Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease Phase 2/Phase 3
Completed NCT00233064 - Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) Phase 4
Recruiting NCT05866302 - Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Not yet recruiting NCT06326957 - Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE) N/A
Completed NCT01326611 - Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants Phase 4
Completed NCT05776264 - Exercise Strategies to Motivate and Relieve Stress N/A
Completed NCT03773991 - Dyspnea Assessment in Hemodialysis Patients
Completed NCT02055339 - Pilot Study Comparing Different Modes of Non-invasive Ventilation for the Oral Feeding of Preterm Infants N/A
Withdrawn NCT03673566 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO N/A
Completed NCT02426112 - Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children Phase 3
Recruiting NCT00710112 - Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
Withdrawn NCT03673579 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB N/A
Completed NCT03385330 - BPD Saturation TARgeting N/A